# VARUBI
> **NDA206500** · New Drug Application · Sponsor: TERSERA · Approved 2015-09-01
## Drug
- **FDA Application Number:** NDA206500
- **Application type:** New Drug Application
- **Brand name:** VARUBI
- **Generic name:** ROLAPITANT
- **Active ingredients:** ROLAPITANT HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TERSERA
- **Manufacturer:** TerSera Therapeutics LLC
- **First approval:** 2015-09-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206500)
---
*MORVS · CC0 1.0*